Have you been reading this board for the past two months? Your question about “pill burden” has been discussed ad nauseam.
The relapse rate of any HCV regimen is subsumed in the SVR12 rate—i.e. anyone who relapses during treatment does not achieve SVR12 by definition. Thus, citing the relapse rate as though it were a separate and highly relevant efficacy metric is misguided.
Market Data 
Markets 
AI
